Planning and Evaluation Team
The Planning and Evaluation Team (PET) leads and supports strategic planning and performance measurement efforts across the Office of Global Policy and Strategy (OGPS). PET strengthens OGPS’ capacity to systematically plan, track and measure program results, and ensure alignment with agency priorities. In addition, PET conducts measurements and analyses to strengthen risk-based decision-making, and effectively demonstrates change and impact over time using data and analytics.
- Leads strategic planning,
priority-setting, and metrics
development and
implementation for FDA
international programs and
the overseas offices, ensuring
alignment with FDA priorities
and resource allocations.
![Strategic Planning and implimentation](https://public4.pagefreezer.com:443/content/FDA/03-02-2023T22:45/https://www.fda.gov/files/image-1a_4.png)
- Serves as the OGPS resource
for quantitative and
qualitative research and
analysis on emerging issues. - Supports the communications
team in reporting and
engagement activities.
![Data Management and Analysis](https://public4.pagefreezer.com:443/content/FDA/03-02-2023T22:45/https://www.fda.gov/files/image-1b_1.png)
- Engages with OGPS offices
and FDA centers on planning,
monitoring and evaluation
activities in support of OGPS
goals.
![Evaluation and Learning](https://public4.pagefreezer.com:443/content/FDA/03-02-2023T22:45/https://www.fda.gov/files/image-1c.png)